The Head of the Hematopoietic and Lymphoid Tumors Group at IDIBELL and Head of Clinical Hematology at ICO L’Hospitalet, Dr. Anna Sureda, has been appointed President of the European Society for Bone Marrow Transplantation (EBMT). This appointment represents recognition of her professional life dedicated to hematopoietic stem cell transplantation and cell therapies.
In fact, Sureda has been associated with the Society before, first as the director of the Lymphoma Working Party and later as the organization’s secretary. It should be noted that of the 17 presidents that this society has had to date, Anna Sureda will be the third woman to take office.
What is the European Society for Bone Marrow Transplantation?
EBMT is a community of health professionals dedicated to innovation, research, and advancement in cellular and stem cell-based therapies to improve the lives of patients with blood-related diseases.
Its activity is focused on promoting all the knowledge associated with hematopoietic stem cell transplantation from all sources and types of donors, including basic and clinical research, education, standardization, quality control and the accreditation of transplantation procedures.
It is currently made up of more than 5,000 members spread over more than 60 countries. One of the main activities of the society is an annual meeting in which thousands of people participate, between international experts, scientists, doctors, nurses, other health professionals and patients. This important forum is an essential tool to guarantee and promote dialogue and information exchange, education and scientific productivity in this field.
The Bellvitge Biomedical Research Institute (IDIBELL) is a biomedical research center created in 2004. It is participated by the Bellvitge University Hospital and the Viladecans Hospital of the Catalan Institute of Health, the Catalan Institute of Oncology, the University of Barcelona and the City Council of L’Hospitalet de Llobregat.
IDIBELL is a member of the Campus of International Excellence of the University of Barcelona HUBc and is part of the CERCA institution of the Generalitat de Catalunya. In 2009 it became one of the first five Spanish research centers accredited as a health research institute by the Carlos III Health Institute. In addition, it is part of the “HR Excellence in Research” program of the European Union and is a member of EATRIS and REGIC. Since 2018, IDIBELL has been an Accredited Center of the AECC Scientific Foundation (FCAECC).